Dengming Xiao

发表

The discovery of a selective, high affinity A(2B) adenosine receptor antagonist for the potential treatment of asthma.

D. Zeng, N. Chu, K. Leung, 2005, Bioorganic & medicinal chemistry letters.

Discovery and preclinical pharmacology of a selective ATP-competitive Akt inhibitor (GDC-0068) for the treatment of human tumors.

Jun Liang, J. Blake, B. Brandhuber, 2012, Journal of medicinal chemistry.

Discovery of pyrrolopyrimidine inhibitors of Akt.

Tyler T. Risom, S. Gross, J. Blake, 2010, Bioorganic & medicinal chemistry letters.

Highly Enantioselective Hydrogenation of Acyclic Imines Catalyzed by Ir–f‐Binaphane Complexes

Xumu Zhang, D. Xiao, Dengming Xiao, 2001 .

Synthesis of a novel chiral binaphthyl phospholane and its application in the highly enantioselective hydrogenation of enamides.

Xumu Zhang, Zhaoguo Zhang, Z. Zhang, 1999, Organic letters.

Highly Enantioselective Hydrogenation of Simple Ketones Catalyzed by a Rh-PennPhos Complex.

Xumu Zhang, P. Cao, D. Xiao, 1998, Angewandte Chemie.

CT-721, a Potent Bcr-Abl Inhibitor, Exhibits Excellent In Vitro and In Vivo Efficacy in the Treatment of Chronic Myeloid Leukemia

Ying Sun, De-guang Sun, Huan Wang, 2017, Journal of Cancer.

Asymmetric [3 + 2] Cycloaddition of 2,3-Butadienoates with Electron-Deficient Olefins Catalyzed by Novel Chiral 2,5-Dialkyl-7-phenyl-7- phosphabicyclo[2.2.1]heptanes

G. Zhu, Xumu Zhang, P. Cao, 1997 .

Discovery of dihydrothieno- and dihydrofuropyrimidines as potent pan Akt inhibitors.

Tyler T. Risom, J. Blake, B. Brandhuber, 2010, Bioorganic & medicinal chemistry letters.

Asymmetric Formation of Quaternary Carbon Centers Catalyzed by Novel Chiral 2,5-Dialkyl-7-phenyl-7-phosphabicyclo[2.2.1]heptanes

Xumu Zhang, Zhaogen Chen, D. Xiao, 1998 .

Rhodium-hydroxyl bisphospholane catalyzed highly enantioselective hydrogenation of dehydroamino acids and esters

Xumu Zhang, Zhaoguo Zhang, Wenge Li, 1999 .